摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

palmerolide (A) | 942304-04-3

中文名称
——
中文别名
——
英文名称
palmerolide (A)
英文别名
palmerolide A;[(2R,4E,6E,10R,11R,12E,14R,18E)-11,14-dihydroxy-4-methyl-2-[(2R,3E,5E)-4-methyl-6-(3-methylbut-2-enoylamino)hexa-3,5-dien-2-yl]-20-oxo-1-oxacycloicosa-4,6,12,18-tetraen-10-yl] carbamate
palmerolide (A)化学式
CAS
942304-04-3
化学式
C33H48N2O7
mdl
——
分子量
584.753
InChiKey
HEOKDDVDVGNHMR-LGIDDDSOSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    5.4
  • 重原子数:
    42
  • 可旋转键数:
    7
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.48
  • 拓扑面积:
    148
  • 氢给体数:
    4
  • 氢受体数:
    7

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • Total Synthesis of the Originally Proposed and Revised Structures of Palmerolide A and Isomers Thereof
    作者:K. C. Nicolaou、Ya-Ping Sun、Ramakrishna Guduru、Biswadip Banerji、David Y.-K. Chen
    DOI:10.1021/ja710485n
    日期:2008.3.1
    Palmerolide A is a recently disclosed marine natural product possessing striking biological properties, including potent and selective activity against the melanoma cancer cell line UACC-62. The total syntheses of five palmerolide A stereoisomers, including the originally proposed (1) and the revised [ent-(19-epi-20-epi-1)] structures, have been accomplished. The highly convergent and flexible strategy
    Palmerolide A 是最近公开的一种海洋天然产物,具有惊人的生物学特性,包括针对黑色素瘤癌细胞系 UACC-62 的有效和选择性活性。五种palmerolide A立体异构体的全合成,包括最初提出的(1)和修改后的[ent-(19-epi-20-epi-1)]结构,已经完成。为这些综合开发的高度收敛和灵活的策略涉及构建关键构建块 2、19-epi-2、20-epi-2、ent-2、3、ent-3、4 和 ent-4,以及它们的组装和细化目标化合物。对于构建单元的结合,采用了Stille偶联反应、Yamaguchi酯化、Horner-Wadsworth-Emmons烯化和闭环复分解反应,后者对于palmerolide结构的大环的立体选择性形成至关重要。还研究了 Horner-Wadsworth-Emmons 烯化和 Yamaguchi 内酯化,并发现作为构建 Palmerolide
  • PALMEROLIDES: METHODS OF PREPARATION AND DERIVATIVES THEREOF
    申请人:DE BRABANDER Jef K.
    公开号:US20080249162A1
    公开(公告)日:2008-10-09
    Organic compounds having Formulas I and II are provided where the variables have the values described herein. Pharmaceutical formulations include the organic compounds or pharmaceutically acceptable salts thereof and a pharmaceutically acceptable carrier can be prepared. Methods of preparing the compounds includes deprotecting protected precursor compounds. Methods of treating cancer or inhibiting ATPase include administering the organic compounds to a subject in need thereof.
    提供具有化学式I和II的有机化合物,其中变量具有此处描述的值。药物配方包括该有机化合物或其药用可接受盐以及药用可接受载体可制备。制备该化合物的方法包括去保护受保护的前体化合物。治疗癌症或抑制ATP酶的方法包括将有机化合物用于需要的对象。
  • Cytotoxin compounds and methods of isolation
    申请人:UNIVERSITY OF SOUTH FLORIDA
    公开号:US10815212B2
    公开(公告)日:2020-10-27
    The present invention concerns groups of compounds derived from tunicates of the Synoicum species, as well as to pharmaceutical compositions comprising these compounds, and uses thereof. Extracts from tunicates show selective toxicity against several different cancer cell lines in the NCI 60 cell line panel. These compounds are useful in the effective treatment of cancers, particularly malignant melanomas, colon cancer, and renal cancer cell lines.
    本发明涉及从鳞栉水母属鳞栉水母中提取的几组化合物,以及包含这些化合物的药物组合物及其用途。鳞茎萃取物对 NCI 60 细胞系中几种不同的癌细胞系具有选择性毒性。这些化合物可用于有效治疗癌症,特别是恶性黑色素瘤、结肠癌和肾癌细胞系。
  • Total Synthesis of the Originally Proposed and Revised Structures of Palmerolide A
    作者:K. C. Nicolaou、Ramakrishna Guduru、Ya-Ping Sun、Biswadip Banerji、David Y.-K. Chen
    DOI:10.1002/anie.200702243
    日期:2007.8.3
  • Palmerolide A, a Cytotoxic Macrolide from the Antarctic Tunicate <i>Synoicum </i><i>a</i><i>dareanum</i>
    作者:Thushara Diyabalanage、Charles D. Amsler、James B. McClintock、Bill J. Baker
    DOI:10.1021/ja0588508
    日期:2006.5.1
    Palmerolide A, a 20-membered macrocyclic polyketide bearing carbamate and vinyl amide functionality, was isolated from the tunicate Synoicum adareanum collected from the vicinity of Palmer Station on the Antarctic Peninsula. Palmerolide A displays potent and selective cytotoxicity toward melanoma (UACC-66 LC50 = 0.018 muM) and appears to operate via inhibition (IC50 = 2 nM) of V-ATPase.
查看更多